Skip to main content

$0.315 0.010 (3.28%)

High

$0.32

Low

$0.30

Trades

243

Turnover

$627,825

Volume

2,012,212
30 June 2023 at 4:10pm
Register to track IMM and receive email alerts.

[ARTICLE] Telix Pharma buys Swiss cancer stem cell therapy unit

A news article has been posted about Immutep on the AFR. The article was published around , on 30 November 2020 at 11:06am.

The Australian late stage biotech inked its second deal in a month - a biotech aiming to treat blood cancers and immunodeficiency diseases.

Read Article

IMM was $0.27 at the close of trade on 27 November 2020

Find all articles about Immutep, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

Register to track IMM and receive email alerts.